Letters

The GMC: expediency before principle

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7485.253-b (Published 27 January 2005) Cite this as: BMJ 2005;330:253

Proceed with caution

  1. Stephen F Hayes (stephen.hayes1@virgin.net), freelance general practi
  1. Botley, Hampshire SO30 2AA

EDITOR—When a new drug is introduced, three questions must be asked and as far as possible answered before it comes into widespread use:

  1. Does it work for the condition in question?

  2. Is it safe? (In particular, are there any potential side effects that may be worse than the disease?)

  3. Is it affordable?

The drug must also be compared with other agents and …

View Full Text

Sign in

Log in through your institution

Subscribe